Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.
Oumaima Sahbani, PharmD
Advertisement
Oumaima Sahbani, PharmD, is a PGY-1 pharmacy resident at UConn John Dempsey Hospital at UConn Health, Farmington, CT
Articles by Oumaima Sahbani, PharmD
Advertisement
Latest Updated Articles
- Delafloxacin (Baxdela) for Acute Bacterial Skin Infections
Published: December 6th 2017 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
Pharmacies Should Be Proactive in Expanding Clinical Services, Reimbursement Pathways | NCPA 2025
4
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
5
